Literatur
Schuster AK, Elflein HM, Pokora R, Urschitz MS (2017) Prevalence and risk factors of myopia in children and adolescents in Germany – results of the KiGGS survey. Klin Padiatr 229:234–240
Williams KM et al (2015) Prevalence of refractive error in Europe: the European Eye Epidemiology (E(3)) Consortium. Eur J Epidemiol 30:305–315
Holden BA et al (2016) Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 123:1036–1042
Wesemann W (2017) Analysis of spectacle lens prescriptions shows no increase of myopia in Germany from 2000 to 2015. Ophthalmologe. https://doi.org/10.1007/s00347-017-0601-0
Flitcroft DI (2012) The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res 31:622–660
Tedja MS et al (2018) Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error. Nat Genet 50:834–848
Jones LA et al (2007) Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci 48:3524–3532
Jones-Jordan LA et al (2010) Early childhood refractive error and parental history of myopia as predictors of myopia. Invest Ophthalmol Vis Sci 51:115–121
French AN, Ashby RS, Morgan IG, Rose KA (2013) Time outdoors and the prevention of myopia. Exp Eye Res 114:58–68
Xiong S et al (2017) Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol (Copenh) 95:551–566
He M et al (2015) Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. JAMA 314:1142–1148
Jin J‑X et al (2015) Effect of outdoor activity on myopia onset and progression in school-aged children in northeast China: the Sujiatun Eye Care Study. BMC Ophthalmol 15:73
Gwiazda J, Deng L, Manny R, Norton TT, COMET Study Group (2014) Seasonal variations in the progression of myopia in children enrolled in the correction of myopia evaluation trial. Invest Ophthalmol Vis Sci 55:752–758
Wu P‑C et al (2018) Myopia prevention and outdoor light intensity in a school-based cluster randomized trial. Ophthalmology 125:1239–1250
Karouta C, Ashby RS (2014) Correlation between light levels and the development of deprivation myopia. Invest Ophthalmol Vis Sci 56:299–309
Mountjoy E et al (2018) Education and myopia: assessing the direction of causality by mendelian randomisation. BMJ 361:k2022
Ip JM, Rose KA, Morgan IG, Burlutsky G, Mitchell P (2008) Myopia and the urban environment: findings in a sample of 12-year-old Australian school children. Invest Ophthalmol Vis Sci 49:3858–3863
Prousali E et al (2017) Interventions to control myopia progression in children: protocol for an overview of systematic reviews and meta-analyses. Syst Rev 6:188
Wolffsohn JS et al (2016) Global trends in myopia management attitudes and strategies in clinical practice. Contact Lens Anterior Eye 39:106–116
Lagrèze WA, Schaeffel F (2017) Preventing myopia. Dtsch Arztebl Int 114:575–580
Derby H (1874) On the atropine treatment of acquired and progressive myopia. Trans Am Ophthalmol Soc 2:139–154
Huang J et al (2016) Efficacy comparison of 16 interventions for myopia control in children: a network Meta-analysis. Ophthalmology. https://doi.org/10.1016/j.ophtha.2015.11.010
Gong Q et al (2017) Efficacy and adverse effects of atropine in childhood myopia: a Meta-analysis. JAMA Ophthalmol 135:624–630
Chia A, Lu Q‑S, Tan D (2016) Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01 % Eyedrops. Ophthalmology. https://doi.org/10.1016/j.ophtha.2015.07.004
Lagrèze WA (2016) Myopia. Ophthalmologe. https://doi.org/10.1007/s00347-016-0384-8
Polling JR, Kok RGW, Tideman JWL, Meskat B, Klaver CCW (2016) Effectiveness study of atropine for progressive myopia in Europeans. Eye 30:998–1004
Kollbaum PS, Jansen ME, Tan J, Meyer DM, Rickert ME (2013) Vision performance with a contact lens designed to slow myopia progression. Optom Vis Sci 90:205–214
Lin H‑J et al (2014) Overnight orthokeratology is comparable with atropine in controlling myopia. BMC Ophthalmol 14:40
Cho P, Cheung S‑W (2017) Protective role of orthokeratology in reducing risk of rapid axial elongation: a reanalysis of data from the ROMIO and TO-SEE studies. Invest Ophthalmol Vis Sci 58:1411–1416
Chen C, Cheung SW, Cho P (2013) Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci 54:6510–6517
Tsukiyama J, Miyamoto Y, Higaki S, Fukuda M, Shimomura Y (2008) Changes in the anterior and posterior radii of the corneal curvature and anterior chamber depth by orthokeratology. Eye Contact Lens 34:17–20
Cheung S‑W, Cho P (2013) Validity of axial length measurements for monitoring myopic progression in orthokeratology. Invest Ophthalmol Vis Sci 54:1613–1615
Hung L‑F et al (2018) The adenosine receptor antagonist, 7‑methylxanthine, alters Emmetropizing responses in infant macaques. Invest Ophthalmol Vis Sci 59:472–486
Redaktionskomitee
Prof. Dr. Wolf A. Lagrèze, Freiburg (federführend)
Prof. Dr. med. Bernd Bertram, Aachen
Prof. Dr. Michael P. Schittkowski, Göttingen
Prof. Dr. rer. nat. Frank Schaeffel, Tübingen
Prof. Dr. Focke Ziemssen, Tübingen
Author information
Authors and Affiliations
Consortia
Ethics declarations
Interessenkonflikt
Siehe Tab. 1 im Anhang
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Diese Stellungnahme erscheint ebenfalls in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, Georg Thieme Verlag, Stuttgart.
Anhang
Anhang
Rights and permissions
About this article
Cite this article
Berufsverband der Augenärzte Deutschlands e. V. (BVA)., Deutsche Ophthalmologische Gesellschaft (DOG). Empfehlungen bei progredienter Myopie im Kindes- und Jugendalter. Ophthalmologe 116, 340–345 (2019). https://doi.org/10.1007/s00347-019-0874-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-019-0874-6